Table 3.
Clinical-pathological characteristics of chest wall lesions in 345 patients with/without skin involvement.
| Factor | Skin involvement (n = 198) | Non-skin involvement (n = 147) | p |
|---|---|---|---|
| ER | 0.659 | ||
| <1% | 71 (35.9%) | 51 (34.7%) | |
| ≥1% | 108 (54.5%) | 86 (58.5%) | |
| PR | 0.226 | ||
| <1% | 87 (43.9%) | 76 (51.7%) | |
| ≥1% | 92 (46.5%) | 61 (41.5%) | |
| HER2 | 0.527 | ||
| Positive | 48 (24.2%) | 43 (29.3%) | |
| Negative | 114 (57.6%) | 87 (59.2%) | |
| Ki-67 | 0.237 | ||
| <15% | 26 (13.1%) | 25 (17.0%) | |
| ≥15% | 138 (69.7%) | 92 (62.6%) | |
| Systemic treatment for CWR | 0.519 | ||
| Yes | 183 (92.4%) | 133 (90.5%) | |
| No | 15 (7.6%) | 14 (9.5%) | |
| Radiotherapy for CWR | 0.360 | ||
| Yes | 66 (33.3%) | 56 (38.1%) | |
| No | 132 (66.7%) | 91 (61.9%) |